
Leveraging Digital Technology and Artificial Intelligence to Describe the Real-World Belgian Chronic Lymphocytic Leukemia Patient Population: The BE-CLLEAR Study.
AI in CLL Research: 586 Patients Analyzed, 29.7% Started Treatment, 42.8% TP53 Aberrations. 📊💉









